(Q36949784)

17 August 2017

1 reference

title

Clinical prognosis in BRAF-mutated PTC. (English)

1 reference

17 August 2017

Efisio Puxeddu

1

1 reference

PubMed ID

17891237

17 August 2017

Sonia Moretti

series ordinal

2

1 reference

17 August 2017

1 July 2007

1 reference

Arquivos Brasileiros de Endocrinologia e Metabologia

17 August 2017

1 reference

17 August 2017

51

1 reference

17 August 2017

5

1 reference

17 August 2017

736-747

1 reference

Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients

17 August 2017

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

Is the EORTC prognostic index of thyroid cancer valid in differentiated thyroid carcinoma? Retrospective multivariate analysis of differentiated thyroid carcinoma with long follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

Prognostic factors and risk group analysis in follicular carcinoma of the thyroid

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

Life expectancy in differentiated thyroid cancer: a novel approach to survival analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high-risk group of papillary and follicular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

Prognostic Factors Associated with the Survival of Patients Developing Loco-Regional Recurrences of Differentiated Thyroid Carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

Gene-expression profiling in differentiated thyroid cancer--a viable strategy for the practice of genomic medicine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

BRAF mutation in thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

Mutations of the BRAF gene in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

A new BRAF gene mutation detected in a case of a solid variant of papillary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAF(V599lns)).

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

Biochemical and molecular characterization of the novel BRAF(V599Ins) mutation detected in a classic papillary thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

BRAF mediates RET/PTC-induced mitogen-activated protein kinase activation in thyroid cells: functional support for requirement of the RET/PTC-RAS-BRAF pathway in papillary thyroid carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

Targeted expression of BRAFV600E in thyroid cells of transgenic mice results in papillary thyroid cancers that undergo dedifferentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

BRAF T1796A transversion mutation in various thyroid neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

BRAF mutations typical of papillary thyroid carcinoma are more frequently detected in undifferentiated than in insular and insular-like poorly differentiated carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

BRAF mutations in anaplastic thyroid carcinoma: implications for tumor origin, diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

Conditional BRAFV600E expression induces DNA synthesis, apoptosis, dedifferentiation, and chromosomal instability in thyroid PCCL3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

Conditional expression of RET/PTC induces a weak oncogenic drive in thyroid PCCL3 cells and inhibits thyrotropin action at multiple levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

Conditional activation of RET/PTC3 and BRAFV600E in thyroid cells is associated with gene expression profiles that predict a preferential role of BRAF in extracellular matrix remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

Loss of p53 promotes anaplasia and local invasion in ret/PTC1-induced thyroid carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

Altered gene expression in immunogenic poorly differentiated thyroid carcinomas from RET/PTC3p53-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

Expression of tpo mRNA in thyroid tumors: quantitative PCR analysis and correlation with alterations of ret, Braf , ras and pax8 genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

Influence of the BRAF V600E mutation on expression of vascular endothelial growth factor in papillary thyroid cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

BRAF mutations in an Italian cohort of thyroid cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

BRAF(V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

No correlation between BRAFV600E mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

High prevalence and possible de novo formation of BRAF mutation in metastasized papillary thyroid cancer in lymph nodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

Lymphatic mapping establishes the role of BRAF gene mutation in papillary thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

Low frequency of BRAFT1796A mutations in childhood thyroid carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

Frequency of BRAF T1796A mutation in papillary thyroid carcinoma relates to age of patient at diagnosis and not to radiation exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

Mutational activation of BRAF is not a major event in sporadic childhood papillary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

The BRAFV600E mutation is not associated with poor prognostic factors in Korean patients with conventional papillary thyroid microcarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

Correlation Between Genetic Alterations and Microscopic Features, Clinical Manifestations, and Prognostic Characteristics of Thyroid Papillary Carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

Alternative mutations of BRAF, RET and NTRK1 are associated with similar but distinct gene expression patterns in papillary thyroid cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302007000500011

The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells

21 January 2018

2 references

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1172/JCI200522758

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1172/JCI22758

Identifiers

DOI

10.1590/S0004-27302007000500011

1 reference

17 August 2017

1 reference

PubMed ID

17891237